Furosemide Dosage Recommendations

Akut Kalp Yetersizliğinde Dozaj

The European Heart Journal recommends an initial dose of 20-40 mg IV furosemide for new-onset acute heart failure patients 1
For patients on chronic diuretic therapy, the initial IV dose should be at least equivalent to the oral dose, according to the European Heart Journal 1
Diuretics can be administered as intermittent boluses or continuous infusions, and the dose should be adjusted based on the patient's symptoms and clinical status, as stated by the European Heart Journal 1
The total furosemide dose in the first 6 hours should be less than 100 mg and less than 240 mg in the first 24 hours for acute heart failure patients, as recommended by the European Heart Journal, but cited in Praxis Medical Insights 2

In advanced heart failure, doses above 160 mg per day indicate the need for treatment escalation, according to Praxis Medical Insights 2
For patients with cirrhosis and ascites, the maximum dose is 160 mg per day, usually in combination with spironolactone, as recommended by Praxis Medical Insights 2

The European Heart Journal recommends regular monitoring of symptoms, urine output, renal function, and electrolytes during furosemide treatment 1
Patients with significant hypovolemia, hypotension (SBP <90 mmHg), severe hyponatremia, acidosis, or anuria should avoid furosemide, as stated by Praxis Medical Insights 2
High-dose furosemide (>6 mg/kg/day) should not be administered for more than 1 week, according to Praxis Medical Insights 2

In cases of diuretic resistance, furosemide can be combined with thiazides (hydrochlorothiazide 25 mg) or aldosterone antagonists (spironolactone 25-50 mg), as recommended by Praxis Medical Insights 2
For patients with cirrhosis and ascites, combination therapy with spironolactone is recommended from the start, according to Praxis Medical Insights 2

In acute situations requiring rapid diuresis, IV administration is preferred, as stated by Praxis Medical Insights 2
In patients with cirrhosis, oral administration is preferred due to good bioavailability and to avoid acute decreases in GFR associated with IV administration, according to Praxis Medical Insights 2
Infusions should be administered over 5-30 minutes to prevent hearing loss, as recommended by Praxis Medical Insights 2